iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes

Recruiting now · Not applicable

Conditions studied: Gestational Diabetes, Type2 Diabetes, Pregnancy in Diabetic

In brief

The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT

Key facts

Study ID

NCT04206748

Run by

The University of Texas Health Science Center, Houston

People needed

200

Starts

2019-11-12

Expected to finish

2022-11-01

Last updated by the study team

2021-09-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• All patients >/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
• Non-anomalous singletons
• Ability to provide informed consent

You may not qualify if…

• Patients with Type 1 diabetes
• Patients with fetal major congenital abnormalities
• Patients identified/referred after 30.6 weeks

Where it is running

• The University of Texas Health Science Center at Houston — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.